Results 1 to 10 of about 363,138 (370)

CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future [PDF]

Frontiers in Oncology, 2022
In recent years, with the breakthrough of CAR-T cells in the treatment of hematological tumors, they are increasingly being used to treat solid tumors, including urologic neoplasms.
Zhengchao Zhang, Zhengchao Zhang, Dong Li, Heng Yun, Wei Liu, Keqiang Chai, Jie Tong, Tongwei Zeng, Zhenghua Gao, Yongqiang Xie   +9 more
doaj   +7 more sources

Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges [PDF]

Frontiers in Oncology, 2023
At present, studies have found that c-Met is mainly involved in epithelial-mesenchymal transition (EMT) of tumor tissues in urologic neoplasms. Hepatocyte growth factor (HGF) combined with c-Met promotes the mitosis of tumor cells, and then induces ...
Pengxiao Su, Ming Zhang, Xin Kang
doaj   +7 more sources

Microbiome in urologic neoplasms: focusing on tumor immunity [PDF]

Frontiers in Immunology
Urological tumors are an important disease affecting global human health, and their pathogenesis and treatment have been the focus of medical research.
Jun Zou, Baisheng Xu, Hongbing Gao, Peiyue Luo, Tao Chen, Huanglin Duan   +5 more
doaj   +5 more sources

Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists. [PDF]

Virchows Arch
Oncocytic renal neoplasms are a major source of diagnostic challenge in genitourinary pathology; however, they are typically nonaggressive in general, raising the question of whether distinguishing different subtypes, including emerging entities, is ...
Mohanty SK, Lobo A, Jha S, Sangoi AR, Akgul M, Trpkov K, Hes O, Mehra R, Hirsch MS, Moch H, Smith SC, Shah RB, Cheng L, Amin MB, Epstein JI, Parwani AV, Delahunt B, Desai S, Przybycin CG, Manini C, Luthringer DJ, Sirohi D, Jain D, Midha D, Jain E, Maclean F, Giannico GA, Paner GP, Martignoni G, Al-Ahmadie HA, McKenney J, Srigley JR, Lopez JI, Kunju LP, Browning L, Aron M, Picken MM, Tretiakova M, Zhou M, Sable M, Kuroda N, Pattnaik N, Gupta NS, Rao P, Fine SW, Mishra P, Adhya AK, Kulkarni BN, Dixit M, Baisakh MR, Arora S, Sancheti S, Menon S, Wobker SE, Tickoo SK, Kaushal S, Soni S, Kandukuri S, Sharma S, Mitra S, Reuter VE, Malik V, Rao V, Chen YB, Williamson SR.   +64 more
europepmc   +12 more sources

Updates in Histologic Grading of Urologic Neoplasms [PDF]

Archives of Pathology & Laboratory Medicine, 2020
CONTEXT.— Tumor histology offers a composite view of the genetic, epigenetic, proteomic, and microenvironmental determinants of tumor biology. As a marker of tumor histology, histologic grading has persisted as a highly relevant factor in risk ...
Travis Rice‐Stitt, Aida Valencia‐Guerrero, Kristine M. Cornejo, Chin‐Lee Wu   +3 more
semanticscholar   +5 more sources

Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists [PDF]

Human Pathology, 2017
Renal oncocytoma and chromophobe renal cell carcinoma have been long recognized as distinct tumors; however, it remains unknown if uniform diagnostic criteria are used to distinguish these tumor types in practice. A survey was distributed to urologic pathologists regarding oncocytic tumors. Responses were received from 17 of 26 invitees. Histologically,
Sean R. Williamson, Ramya Gadde, Kiril Trpkov, Michelle S. Hirsch, John R. Srigley, Victor E. Reuter, Liang Cheng, Lakshmi P. Kunju, Ravi Barod, Craig Rogers, Brett Delahunt, Ondřej Hes, John N. Eble, Ming Zhou, Jesse K. McKenney, Guido Martignoni, Stewart Fleming, David J. Grignon, Holger Moch, Nilesh Gupta   +19 more
semanticscholar   +7 more sources

Operations for Urologic Malignant Tumors or Suspected Neoplasms in a Resource-Limited Setting: Last Decade Experience in Cameroon

Cancer Science & Research, 2019
Within the framework of the treatment of cancer, surgery plays a key role. Urological cancer incidence is increasing and will become a more serious issue in the future.
T Djeumi, ML Guifo, Achille Aurèle Mbassi   +2 more
openalex   +2 more sources

Urinary microbiome profile in men with genitourinary malignancies [PDF]

Investigative and Clinical Urology, 2022
Purpose: Recent advances in molecular biology technology have allowed identification of microbial communities in the urinary tract, and urinary microbiome is associated with various urological diseases. In this study, we aimed to characterize the urinary
Hyun Kyu Ahn, Kwangmin Kim, Junhyung Park, Kwang Hyun Kim   +3 more
doaj   +1 more source

Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades [PDF]

Journal of Urologic Oncology, 2023
Purpose This study assessed recent trends in the incidence of urologic cancer and patient survival in Korea. Materials and Methods The incidence of urologic cancer in Korea was calculated based on the Korea National Cancer Incidence Database and the ...
Sang Heon Han, Hyeong Dong Yuk
doaj   +1 more source

The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update

Biomolecules, 2021
Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation reaction of nicotinamide, using S-adenosyl-L-methionine as the methyl donor. Enzyme overexpression has been described in many non-neoplastic diseases, as well as in a wide range of solid
Roberto Campagna, Valentina Pozzi, Graziana Spinelli, Davide Sartini, Giulio Milanese, Andrea Benedetto Galosi, Monica Emanuelli   +6 more
doaj   +1 more source